Pharmacotherapy of chronic kidney disease and mineral bone disorder

Author： Barreto Fellype Carvalho de Oliveira Rodrigo Azevedo Oliveira Rodrigo Bueno Jorgetti Vanda

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.12, Iss.17, 2011-12, pp. : 2627-2640

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Vascular Calcification in Chronic Kidney Disease: Role of Disordered Mineral Metabolism

Current Pharmaceutical Design, Vol. 20, Iss. 37, 2014-11 ,pp. : 5829-5833

Bentham Science Publishers

Access to resources Recommend Favorite

Mitochondrial Dysfunctions in Bipolar Disorder: Effect of the Disease and Pharmacotherapy

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 16, Iss. 2, 2017-02 ,pp. : 176-186

Bentham Science Publishers

Access to resources Recommend Favorite

Evaluation of current pharmacotherapy of chronic obstructive pulmonary disease

By Culpitt S.V. Rogers D.F.

Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 5, 2000-07 ,pp. : 1007-1020

Informa Healthcare

Access to resources Recommend Favorite

Clinical management of chronic kidney disease

By Methven Shona MacGregor Mark S

Clinical Medicine, Vol. 9, Iss. 3, 2009-06 ,pp. : 269-272

Royal College Of Physicians

Access to resources Recommend Favorite

Facing an epidemic of chronic kidney disease

By Griffin Siân V MacGregor Mark S

Clinical Medicine, Vol. 5, Iss. 5, 2005-09 ,pp. : 521-525

Royal College Of Physicians

Access to resources Recommend Favorite